跳至主要内容
临床试验/TCTR20230119007
TCTR20230119007尚未招募3 期

A multicenter prospective randomized controlled trial: Comparison generic alginate Vs original alginate for symptoms controlled in the non-proton pump inhibitors responder GERD

Dr. Kawin Tangvoraphonkchai0 个研究点目标入组 162 人开始时间: 2023年1月19日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
162

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Thai patients aged 18 years and older with a diagnosis of gastroesophageal reflux disease were treated with standard-dose proton pump inhibitors for at least 4 weeks but did not respond to treatment. The criteria for GERD diagnosis are: Typical symptoms of GERD include heartburn and belching at least twice a week. with symptoms continually for 1 month. or with a score greater than or equal to 8 using a standardized questionnaire to help diagnose GERD. (Gastroesophageal Reflux Disease Questionaire (GerdQ)). If the patient has warning symptoms (Alarm symptoms), they must do EGD before.

排除标准

  • Psychiatric problems, Currently using prokinetic or H2 blocker or PCAB or alginate drug, Antiplatelet or NSAIDs using, Pregnancy, Previous surgery of esophagus, Alginate allergy, The patient in question is unable to listen or answer.

研究者

发起方
Dr. Kawin Tangvoraphonkchai

相似试验